# Century Therapeutics (IPSC) — Earnings

IPSC · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ipsc/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.38 |
| EPS estimate | −$0.38 |
| EPS surprise | −1.04% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 14, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1850119/000155837025011575/ipsc-20250630x10q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 14, 2025 | −$0.38 | −$0.38 | -1.04% | — | — |
| Q1 2025 | May 15, 2025 | −$0.01 | $0.89 | 11510.26% | $41.3M | $109.2M |
| Q4 2024 | Mar 19, 2025 | −$0.41 | −$0.41 | 0.00% | $784,429.00 | $4.2M |
| Q3 2024 | Nov 5, 2024 | −$0.45 | −$0.37 | 17.91% | $440,000.00 | $791,000.00 |
| Q2 2024 | Aug 8, 2024 | −$0.45 | −$0.38 | 16.45% | $430,000.00 | $771,000.00 |
| Q1 2024 | May 9, 2024 | −$0.51 | −$0.45 | 12.31% | $210,000.00 | $855,000.00 |
| Q4 2023 | Mar 14, 2024 | −$0.55 | −$0.66 | -20.50% | $1.7M | $265,000.00 |
| Q3 2023 | Nov 9, 2023 | −$0.52 | −$0.55 | -5.51% | $1.3M | $148,000.00 |
| Q2 2023 | Aug 9, 2023 | −$0.54 | −$0.56 | -2.98% | $1.1M | $99,000.00 |
| Q1 2023 | May 11, 2023 | −$0.52 | −$0.53 | -1.20% | $1.5M | $1.7M |
| Q4 2022 | Mar 16, 2023 | −$0.58 | −$0.54 | 7.23% | $2.0M | $521,000.00 |
| Q3 2022 | Nov 10, 2022 | −$0.59 | −$0.53 | 10.83% | $1.1M | $2.2M |
| Q2 2022 | Aug 11, 2022 | −$0.50 | −$0.54 | -8.00% | $1.3M | $1.4M |
| Q1 2022 | May 16, 2022 | −$0.45 | −$0.66 | -45.86% | $10.0M | $1.1M |
| Q4 2021 | Mar 17, 2022 | −$0.48 | −$0.51 | -6.81% | — | — |
| Q3 2021 | Nov 10, 2021 | −$0.40 | −$0.48 | -20.00% | — | — |
| Q2 2021 | Aug 12, 2021 | −$0.40 | −$1.93 | -382.50% | — | — |

## Frequently Asked Questions

### When did Century Therapeutics (IPSC) last report earnings?

Century Therapeutics last reported on Aug 14, 2025, covering fiscal Q2 2025.

### Did IPSC beat earnings estimates?

No. Century Therapeutics reported EPS of −$0.38 for Q2 2025 against a −$0.38 estimate — a 1.04% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).